Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005062 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
A Phase 3 study, sponsored by Gustave Roussy, Cancer Campus, Grand Paris.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00005062 is a Phase 3 study that has completed, run by Gustave Roussy, Cancer Campus, Grand Paris.
The verdict
NCT00005062, a Phase 3 study, has completed, sponsored by Gustave Roussy, Cancer Campus, Grand Paris.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells and prevent the spread of cancer to the brain. It is not yet known if standard-dose radiation therapy is more effective than high-dose radiation therapy in preventing the spread of limited-stage small cell lung cancer cells to the brain. PURPOSE: This randomized phase III trial is comparing two different regimens of radiation therapy to see how well they work in treating patients with limited-stage small cell lung cancer in complete remission.
Interventions
- RADIATION radiation therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-09 |
| Est. Completion | 2005-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005062
The ClinicalTrials.gov registry entry for NCT00005062 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Gustave Roussy, Cancer Campus, Grand Paris, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which radiation therapy is the first listed.
NCT00005062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005062 about?
NCT00005062 is a clinical study titled "Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission". RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells and prevent the spread of cancer to the brain. It is not yet known if standard-dose radiation therapy is more effective than high-dose radiation therapy in preventing the spread of limited-stage small cell lung cancer cells to ...
What is the current status of trial NCT00005062?
This trial is currently completed. It is a Phase 3 study. The study started on 1999-09. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00005062?
The interventions under investigation include: radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00005062?
This trial is sponsored by Gustave Roussy, Cancer Campus, Grand Paris, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.